Literature DB >> 18426367

Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men.

Alan Nyitray1, Carrie M Nielson, Robin B Harris, Roberto Flores, Martha Abrahamsen, Eileen F Dunne, Anna R Giuliano.   

Abstract

In US men, the incidence of anal cancer, the primary cause of which is human papillomavirus (HPV) infection, has increased almost 3-fold in 3 decades; however, little is known about the epidemiology of anal HPV infection, especially in heterosexual men. In 2 US cities, behavioral data and anal biological specimens were collected from 253 men who acknowledged having engaged in sexual intercourse with a woman during the preceding year. On the basis of DNA analysis, overall prevalence of anal HPV infection was found to be 24.8% in 222 men who acknowledged having had no prior sexual intercourse with men. Of the men with anal HPV infection, 33.3% had an oncogenic HPV type. Risk factors independently associated with anal HPV were lifetime number of female sex partners and frequency of sex with females during the preceding month. These results suggest that anal HPV infection may be common in heterosexual men.

Entities:  

Mesh:

Year:  2008        PMID: 18426367     DOI: 10.1086/588145

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

Review 1.  Vaccinations for Anal Squamous Cancer: Current and Emerging Therapies.

Authors:  John Berry; Sean C Glasgow
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

Review 2.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 3.  Human papillomavirus disease and vaccines in adolescents.

Authors:  Anna-Barbara Moscicki
Journal:  Adolesc Med State Art Rev       Date:  2010-08

4.  Frequency of occult high-grade squamous intraepithelial neoplasia and invasive cancer within anal condylomata in men who have sex with men.

Authors:  Hans P Schlecht; Dana K Fugelso; Ryan K Murphy; Katiri T Wagner; John P Doweiko; Joann Proper; Bruce J Dezube; Lori A Panther
Journal:  Clin Infect Dis       Date:  2010-07-01       Impact factor: 9.079

5.  The association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM study.

Authors:  Alan G Nyitray; Fen Peng; Rena S Day; Roberto J Carvalho Da Silva; Maria Luiza Baggio; Jorge Salmerón; Manuel Quiterio; Martha Abrahamsen; Eduardo Lazcano-Ponce; Luisa L Villa; Anna R Giuliano
Journal:  Hum Vaccin Immunother       Date:  2019-04-19       Impact factor: 3.452

6.  Quality of life of homosexual males with genital warts: a qualitative study.

Authors:  Gitte Lee Mortensen; Helle K Larsen
Journal:  BMC Res Notes       Date:  2010-11-04

7.  Sequential Acquisition of Anal Human Papillomavirus (HPV) Infection Following Genital Infection Among Men Who Have Sex With Women: The HPV Infection in Men (HIM) Study.

Authors:  Shitaldas J Pamnani; Alan G Nyitray; Martha Abrahamsen; Dana E Rollison; Luisa L Villa; Eduardo Lazcano-Ponce; Yangxin Huang; Amy Borenstein; Anna R Giuliano
Journal:  J Infect Dis       Date:  2016-08-03       Impact factor: 5.226

8.  Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study.

Authors:  Alan G Nyitray; Dan'elle Smith; Luisa Villa; Eduardo Lazcano-Ponce; Martha Abrahamsen; Mary Papenfuss; Anna R Giuliano
Journal:  J Infect Dis       Date:  2010-05-15       Impact factor: 5.226

Review 9.  Expanding the scope of nursing research in low resource and middle resource countries, regions, and states focused on cervical cancer prevention, early detection, and control.

Authors:  Sandra Millon Underwood; Edith Ramsay-Johnson; Asante Dean; Jori Russ; Ruth Ivalis
Journal:  J Natl Black Nurses Assoc       Date:  2009-12

Review 10.  HPV and anal cancer in HIV-infected individuals: a review.

Authors:  Maarten F Schim van der Loeff; Sofie H Mooij; Oliver Richel; Henry J C de Vries; Jan M Prins
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.